EditGene
Latest round
- Angel
Last raised
- Aug 2024
Total raised
- $1.4M
Investors
- 3
About EditGene
Established in 2017 and based in Guangzhou, China, EditGene is a biotechnology company focusing on the development, service and industrialization of CRISPR/Cas gene editing technology. The company was founded by a returning doctors in the field of gene editing technology. Dr. Zhang Xu, the co-founder in charge of technology development, graduated from the University of Munich, Germany. The company has provided CRO services for domestic research institutes and enterprises, and at the same time opened up sales channels in Western Europe, East Asia, North America and other overseas countries and regions. EditGene offers a range of gene editing services and products, including Editx™ gene editing, Bingo™ point mutation, LION™ cellular targeted insertion and FASST nucleic acid rapid detection. Their services extend to CRO services such as gene knockout, gene overexpression, gene mutation, and library screening for research institutes and pharmaceutical companies. The company generates revenue by providing gene editing services, CRO services, and selling gene editing-related products.
Who invested in EditGene
3 investors across 1 round
See all investors in EditGene
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Aug 5, 2024
Amount
$1.4M
Investors
Questions about EditGene
Who invested in EditGene?
EditGene has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EditGene raised?
EditGene has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did EditGene last raise money?
EditGene's most recent round on record is a Angel, in Aug 2024.
What does EditGene do?
Established in 2017 and based in Guangzhou, China, EditGene is a biotechnology company focusing on the development, service and industrialization of CRISPR/Cas gene editing technology.
Where is EditGene headquartered?
EditGene is headquartered in Guangzhou, China.
Which VCs invest in companies like EditGene?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at EditGene's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like EditGene? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.